IMCC — IM Cannabis Income Statement
0.000.00%
Last trade - 00:00- CA$6.63m
- CA$21.69m
- CA$54.03m
- 35
- 69
- 59
- 54
Annual income statement for IM Cannabis, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 15.9 | 34.1 | 54.3 | 48.8 | 54 |
| Cost of Revenue | |||||
| Gross Profit | -1.31 | 0.025 | 9.48 | 9.85 | 8.45 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 24.1 | 57.1 | 85.1 | 61.6 | 64.3 |
| Operating Profit | -8.24 | -23 | -30.8 | -12.8 | -10.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -28.5 | -0.164 | -26.1 | -9.46 | -12.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -28.7 | -0.664 | -24.9 | -10.2 | -11.8 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -28.7 | -17.8 | -189 | -9.5 | -10.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -28.7 | -17.8 | -189 | -9.5 | -10.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -54.9 | -3.97 | 44 | -4.26 | -3.61 |